News
June 18, 2019

Regenstrief scientist explains how class of drugs may be related to dementia

Regenstrief research scientist Noll Campbell, PharmD, M.S., spoke about a common class of drugs and how it affects the brain on an Indianapolis radio show.

Dr. Campbell was a guest on Caregiver Crossing, which airs every Saturday on 93.1 WIBC. Dr. Campbell addressed the topic of anticholinergics and their potential link to Alzheimer’s and dementia. Anticholinergics are a common class of drug that includes some allergy medications, sleeping pills and many more common medicines.

Dr. Campbell recently received a $3.3 million grant from the National Institute on Aging to conduct the first clinical trial designed to determine if stopping these medications results in sustained improvements in cognition.

Listen to his discussion with the Caregiver Crossing hosts and his advice for people who are taking these medications.

Segment 1

Segment 2

Click here for more information on Caregiver Crossing.

  • Noll Campbell, PharmD, MS

Related News

Rachel Patzer, PhD, MPH, Adam Wilk, PhD, and Kelsey Drewry, PhD, MA

Research letter calls for careful consideration of design and consequences of health disparity incentives in future value-based payment models

INDIANAPOLIS – A research letter published in the New England Journal of Medicine calls for careful consideration of the

Regenstrief Institute conference highlights innovations in public health data modernization

Regenstrief Institute conference highlights innovations in public health data modernization

Regenstrief Institute hosted a one-day conference focused on advancing public health data modernization, drawing professionals from across the public

Rachel Patzer, PhD, MPH

Supply, demand, and a growing US kidney transplant waiting list

Published in JAMA Network Open. Here is a link to the article.  Regenstrief Institute author: Rachel Patzer, PhD, MPH